FIGURE 2 from Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Year: 2024
Type: other
Abstract: Cytotoxicity of TAK-243 on ACC cell lines. A, Concentration–response curve and IC50 values of TAK-243 in ACC cell lines and SW-13. Cell viability after 72 hours under the indicated drug concentrations was measured by the CellTiter-Glo viability assay. B, Expression of ABC transporters (MDR-1, BCRP) and SLFN11 in ACC cell lines and SW-13. Proteins were extracted from each cell line and expression of SLFN11, MDR-1, and BCRP were evaluated by Western blotting. C, Effects of TAK-243 on DNA synthesis and cell cycle. CU-ACC1, CU-ACC2, and NCI-H295R cells were treated with 100 nmol/L TAK-243 for the indicated times and pulse-labeled with EdU (10 µmol/L) for 30 minutes before harvest. Cellular EdU uptake and cell cycle were analyzed by flow cytometry. D, Change in percentage of S-phase after TAK-243 treatment. E, ACC cell lines and SW-13 were treated with TAK-243 at the indicated concentrations for 24 hours, and PARP cleavage was detected by Western blotting.
Authors: Yasuhiro Arakawa, Ukhyun Jo, Suresh Kumar, Nai-Yun Sun, Fathi Elloumi, Anish Thomas, Nitin Roper, Diana Grace Varghese, Naoko Takebe, Xiaohu Zhang, Michele Ceribelli, David O. Holland, Erin Beck, Zina Itkin, Crystal McKnight, Kelli M. Wilson, Jameson Travers, Carleen Klumpp-Thomas, Craig J. Thomas, Chuong D. Hoang, Jonathan M. Hernandez, Jaydira Del Rivero, Yves Pommier
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4392951891